Related Experiment Video
Updated: Dec 23, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
[Research Advance in Anti-lung Cancer Mechanism of Metformin]
Gaoxiang Wang1, Meiqing Xu1,2, Mingran Xie1,2
1Department of Thoracic Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, China.
Abstract:
Metformin, as a first-line drug in the treatment of type 2 diabetes, has been proved to be safe and effective. In recent years, epidemiological studies have found that metformin can inhibit the proliferation and metastasis of lung cancer cells, and is expected to become a new anti-lung cancer drug. Lung cancer is a disease that seriously endangers human health, its morbidity and mortality have been ranked first among all malignant tumors, and the prognosis is poor. In recent years, a great deal of evidence shows that metformin can reduce the risk and mortality of tumors such as lung cancer. Its mechanisms mainly include activating adenosine monophosphate-activated protein kinase pathway, improving hyperinsulinemia and insulin resistance, promoting lung cancer cell apoptosis and inhibiting related inflammatory response. The aim of this article is to reviews the study of metformin on lung cancer.
Insights
Metformin, a type 2 diabetes drug, shows promise in fighting lung cancer by inhibiting cell growth and metastasis. Research explores its potential as a novel anti-lung cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Endocrinology
Background:
- Lung cancer has high morbidity and mortality, with a poor prognosis.
- Metformin is a widely used, safe, and effective first-line treatment for type 2 diabetes.
- Emerging evidence suggests metformin possesses anti-cancer properties, particularly against lung cancer.
Purpose of the Study:
- To review the current research on metformin's effects on lung cancer.
- To explore the potential of metformin as a novel therapeutic agent for lung cancer.
Main Methods:
- Review of epidemiological studies and preclinical research.
- Analysis of proposed molecular mechanisms of metformin's anti-lung cancer activity.
Main Results:
- Metformin has demonstrated inhibition of lung cancer cell proliferation and metastasis in studies.
- Evidence indicates metformin can reduce the risk and mortality associated with lung cancer.
- Key mechanisms include AMPK pathway activation, improved insulin resistance, apoptosis promotion, and anti-inflammatory effects.
Conclusions:
- Metformin exhibits significant potential as an anti-lung cancer drug.
- Further research is warranted to fully elucidate its therapeutic applications in oncology.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...